Overview
Hannerieke Van Den Hout practices in Rotterdam, Netherlands. Van Den Hout is highly rated in 1 condition, according to our data. Their top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Mucopolysaccharidoses (MPS), and Sudden Infant Death Syndrome (SIDS).
Their clinical research consists of co-authoring 10 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Experienced
- Danon DiseaseVan Den Hout isExperienced. Learn about Danon Disease.
- Mucopolysaccharidoses (MPS)Van Den Hout isExperienced. Learn about Mucopolysaccharidoses (MPS).
- Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome)
- Niemann-Pick DiseaseVan Den Hout isExperienced. Learn about Niemann-Pick Disease.
- Pompe DiseaseVan Den Hout isExperienced. Learn about Pompe Disease.
- Sudden Infant Death Syndrome (SIDS)Van Den Hout isExperienced. Learn about Sudden Infant Death Syndrome (SIDS).